http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012318279-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f21c1009c60308a64b8e7dc0bb989632 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate | 2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_665b618d9fe82b1314331159e5bbbfd8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41b2a917644e7647d953222d7c8c6b57 |
publicationDate | 2015-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2012318279-B2 |
titleOfInvention | Use of sulfated glycosaminoglycans for improving the bioavailability of Factor VIII |
abstract | CSL BEARING GMBH 2011_MOO6_A182 HAU/kk 5 Abstract The present invention relates to pharmaceutical preparations comprising one or more Factor Vill and a sulfated glycosaminoglycan for increasing the bioavailability of Factor VIll upon non-intravenous administration. The invention further relates to 10 the combined use of Factor VIII and a sulfated glycosaminoglycan for the treatment and prevention of bleeding disorders, whereby the bioavailability of Factor VIII is increased, and to a method for increasing the bioavailability after non-intravenous administration of Factor VIII by coadminstration of a sulfated glycosaminoglycan. |
priorityDate | 2011-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.